Philip A. Carpino

2.0k total citations
42 papers, 1.1k citations indexed

About

Philip A. Carpino is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Philip A. Carpino has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Philip A. Carpino's work include Regulation of Appetite and Obesity (8 papers), Chemical Synthesis and Analysis (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Philip A. Carpino is often cited by papers focused on Regulation of Appetite and Obesity (8 papers), Chemical Synthesis and Analysis (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Philip A. Carpino collaborates with scholars based in United States and United Kingdom. Philip A. Carpino's co-authors include E. J. Corey, Paul B. Hopkins, Andreas Spaltenstein, Bryan Goodwin, David A. Griffith, V. Margaret Jackson, Jean‐Philippe Fortin, Roger B. Ruggeri, Dennis O. Scott and Robert L. Dow and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and Biochemistry.

In The Last Decade

Philip A. Carpino

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip A. Carpino United States 20 414 365 174 153 143 42 1.1k
Robert J. Chorvat United States 15 364 0.9× 279 0.8× 405 2.3× 177 1.2× 110 0.8× 38 1.1k
Sung‐Eun Yoo South Korea 22 548 1.3× 592 1.6× 130 0.7× 61 0.4× 100 0.7× 107 1.4k
Kang Cheng United States 26 881 2.1× 428 1.2× 106 0.6× 345 2.3× 75 0.5× 70 1.9k
T. Saeki Japan 19 450 1.1× 214 0.6× 94 0.5× 261 1.7× 88 0.6× 60 1.0k
Joachim Mittendorf Germany 18 584 1.4× 435 1.2× 112 0.6× 73 0.5× 327 2.3× 29 1.4k
Laura Caparrotta Italy 20 738 1.8× 168 0.5× 106 0.6× 83 0.5× 194 1.4× 76 1.5k
Fatima Z. Basha Pakistan 19 348 0.8× 554 1.5× 99 0.6× 36 0.2× 193 1.3× 67 1.4k
Ralph Mosley United States 12 698 1.7× 172 0.5× 183 1.1× 143 0.9× 24 0.2× 15 1.2k
David G. Ahern United States 17 508 1.2× 207 0.6× 350 2.0× 65 0.4× 102 0.7× 53 1.2k
Reeba K. Vikramadithyan United States 18 654 1.6× 141 0.4× 95 0.5× 146 1.0× 156 1.1× 27 1.2k

Countries citing papers authored by Philip A. Carpino

Since Specialization
Citations

This map shows the geographic impact of Philip A. Carpino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Carpino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Carpino more than expected).

Fields of papers citing papers by Philip A. Carpino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Carpino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Carpino. The network helps show where Philip A. Carpino may publish in the future.

Co-authorship network of co-authors of Philip A. Carpino

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Carpino. A scholar is included among the top collaborators of Philip A. Carpino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Carpino. Philip A. Carpino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maron, Martin S., Hassan Rastegar, Noreen Dolan, et al.. (2021). Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 163. 91–97. 19 indexed citations
2.
Schwaid, Adam G., Allan R. Reyes, Shawn Cabral, et al.. (2016). Development of a selective activity-based probe for glycosylated LIPA. Bioorganic & Medicinal Chemistry Letters. 26(8). 1993–1996. 3 indexed citations
3.
Rose, Colin R., et al.. (2016). Practical synthesis of capromorelin, a growth hormone secretagogue, via a crystallization-induced dynamic resolution. Bioorganic & Medicinal Chemistry. 25(3). 1000–1003. 4 indexed citations
4.
Petersen, Donna N., Julie A. Hawkins, Kimberly A. Stevens, et al.. (2016). A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation. Cell chemical biology. 23(11). 1362–1371. 68 indexed citations
5.
Jackson, V. Margaret, David A. Price, & Philip A. Carpino. (2014). Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies. Expert Opinion on Investigational Drugs. 23(8). 1055–1066. 20 indexed citations
6.
Nolte, Whitney M., Jean‐Philippe Fortin, Benjamin D. Stevens, et al.. (2014). A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification. Nature Chemical Biology. 10(8). 629–631. 66 indexed citations
7.
Ward, Jessica, Brandon Pabst, Philip A. Carpino, et al.. (2013). Mechanistic Characterization of a 2-Thioxanthine Myeloperoxidase Inhibitor and Selectivity Assessment Utilizing Click Chemistry–Activity-Based Protein Profiling. Biochemistry. 52(51). 9187–9201. 27 indexed citations
8.
Londregan, Allyn T., David W. Piotrowski, Kentaro Futatsugi, et al.. (2013). Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries. Bioorganic & Medicinal Chemistry Letters. 23(5). 1407–1411. 20 indexed citations
9.
Fichtner, Michael, Eun-Sun Lee, Elizabeth Tomlinson, et al.. (2012). Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor. Bioorganic & Medicinal Chemistry Letters. 22(8). 2738–2743. 6 indexed citations
10.
Carpino, Philip A. & Bryan Goodwin. (2010). Diabetes area participation analysis: a review of companies and targets described in the 2008 – 2010 patent literature. Expert Opinion on Therapeutic Patents. 20(12). 1627–1651. 40 indexed citations
11.
Hadcock, John R., Philip A. Carpino, Philip A. Iredale, et al.. (2010). Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) Receptor Antagonist. BMC Pharmacology. 10(1). 9–9. 12 indexed citations
12.
Dow, Robert L., John R. Hadcock, Dennis O. Scott, et al.. (2009). Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: Potent, orally-active 1,4-disubstituted imidazoles. Bioorganic & Medicinal Chemistry Letters. 19(18). 5351–5354. 11 indexed citations
13.
Carpino, Philip A. & Guyu Ho. (2008). Modulators of the ghrelin system as potential treatments for obesity and diabetes. Expert Opinion on Therapeutic Patents. 18(11). 1253–1263. 5 indexed citations
14.
Khabbaz, Kamal R., David DeNofrio, Marwan Kazimi, & Philip A. Carpino. (2004). Revascularization Options for Ischemic Cardiomyopathy: On-Pump and Off-Pump Coronary Artery Bypass Surgery. Cardiology. 101(1-3). 29–36.
15.
Carpino, Philip A.. (2002). Recent developments in ghrelin receptor (GHS-R1a) agonists and antagonists. Expert Opinion on Therapeutic Patents. 12(11). 1599–1618. 17 indexed citations
16.
Pan, Lydia C., Philip A. Carpino, Bruce A. Lefker, et al.. (2001). Preclinical Pharmacology of CP-424,391, an Orally Active Pyrazolidinone-Piperidine Growth Hormone Secretagogue. Endocrine. 14(1). 121–132. 33 indexed citations
17.
Khabbaz, Kamal R., et al.. (2001). Outcome after combined carotid endarterectomy and coronary artery bypass is related to patient selection. Journal of Vascular Surgery. 33(6). 1179–1184. 13 indexed citations
18.
Carpino, Philip A., et al.. (1994). A conformationally restrained series of AT1-selective angiotensin II antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 93–98. 6 indexed citations
19.
Corey, E. J. & Philip A. Carpino. (1989). Enantiospecific total synthesis of pseudopterosins A and E. Journal of the American Chemical Society. 111(14). 5472–5474. 77 indexed citations
20.
Spaltenstein, Andreas, et al.. (1986). A stereocontrolled synthesis of trans-alkene isosteres of dipeptides. Tetrahedron Letters. 27(19). 2095–2098. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert J. Chorvat Breakdown of academic impact, for papers by Sung‐Eun Yoo Breakdown of academic impact, for papers by Kang Cheng Breakdown of academic impact, for papers by T. Saeki Breakdown of academic impact, for papers by Joachim Mittendorf Breakdown of academic impact, for papers by Laura Caparrotta Breakdown of academic impact, for papers by Fatima Z. Basha Breakdown of academic impact, for papers by Ralph Mosley Breakdown of academic impact, for papers by David G. Ahern Breakdown of academic impact, for papers by Reeba K. Vikramadithyan
Rankless by CCL
2026